IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools
 

Search About Journals, Conferences, and Book Series


RSC Drug Discovery Series- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on May 27, 2022

Impact Score

0.38

h-Index

 10

Rank

 25027

SJR

 0.105

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title RSC Drug Discovery Series
Abbreviation RSC Drug Discov. Ser.
Publication Type Book series
Subject Area, Categories, Scope Drug Discovery (Q4)
h-index 10
Overall Rank/Ranking 25027
SCImago Journal Rank (SJR) 0.105
Impact Score 0.38
Publisher Royal Society of Chemistry
Country United Kingdom
ISSN 20413203, 20413211




About RSC Drug Discovery Series


RSC Drug Discovery Series is a book series covering the technologies/fields/categories related to Drug Discovery (Q4). It is published by Royal Society of Chemistry. The overall rank of RSC Drug Discovery Series is 25027. According to SCImago Journal Rank (SJR), this book series is ranked 0.105. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This book series has an h-index of 10. The best quartile for this book series is Q4.

The ISSN of RSC Drug Discovery Series book series is 20413203, 20413211. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. RSC Drug Discovery Series is cited by a total of 67 articles during the last 3 years (Preceding 2021).




RSC Drug Discovery Series Impact Score 2021-2022


The impact score (IS) 2021 of RSC Drug Discovery Series is 0.38, which is computed in 2022 as per its definition. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting


Impact Score Trend


Year wise Impact Score (IS) of RSC Drug Discovery Series. Based on Scopus data.


Year Impact Score (IS)
2022/2023 Coming Soon
2021 0.38
2020 0.25
2019 0.31
2018 0.30
2017 0.39
2016 0.32
2015 0.00
2014 0.00

RSC Drug Discovery Series h-index


  Table Setting

RSC Drug Discovery Series has an h-index of 10. It means 10 articles of this book series have more than 10 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




RSC Drug Discovery Series ISSN


The ISSN of RSC Drug Discovery Series is 20413203, 20413211. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

RSC Drug Discovery Series Rank and SCImago Journal Rank (SJR)


The overall rank of RSC Drug Discovery Series is 25027. According to SCImago Journal Rank (SJR), this book series is ranked 0.105. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


RSC Drug Discovery Series Publisher


Table Setting

RSC Drug Discovery Series is published by Royal Society of Chemistry. It's publishing house is located in United Kingdom. Coverage history of this book series is as following: 2010, 2014-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of RSC Drug Discovery Series is RSC Drug Discov. Ser.. This abbreviation ('RSC Drug Discov. Ser.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in RSC Drug Discovery Series


If your research field is/are related to Drug Discovery (Q4), then please visit the official website of this book series.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Nonautonomous Dynamical Systems journal 19012 Walter de Gruyter GmbH 7 0.71
Endoxa journal 22088 Universidad Nacional de Educacion a Distancia (UNED) 2 0.14
Fire Ecology journal 4141 Association for Fire Ecology 33 4.91
Visual Studies journal 16290 Routledge 43 0.66
Climate of the Past journal 1403 European Geosciences Union 82 4.30
Asian Journal of WTO and International Health Law and Policy journal 24923 National Taiwan University Press : Asian Center for WTO & International Health Law and Policy 8 0.00
Empan journal 24947 Editions Eres 6 0.04
Journal of Hydrology: Regional Studies journal 2960 Elsevier BV 43 5.29
International Journal of Management Reviews journal 407 Wiley-Blackwell Publishing Ltd 116 8.95
Quaderns de Filologia: Estudis Literaris journal 18498 Universitat de Valencia 1 0.06

Check complete list



Jasper


Year wise Impact Score (IS) of RSC Drug Discovery Series

Impact Score Table

Year Impact Score (IS)
2022/2023 Coming Soon
2021 0.38
2020 0.25
2019 0.31
2018 0.30
2017 0.39
2016 0.32
2015 0.00
2014 0.00



Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Cell Chemical Biology
Elsevier Inc. | United States

Protein and Cell
Springer-Verlag GmbH and Co. KG | Germany

Medicinal Research Reviews
John Wiley and Sons Inc. | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Emerging Microbes and Infections
Nature Publishing Group | United Kingdom

Nucleic Acid Therapeutics
Mary Ann Liebert Inc. | United States

Molecular Therapy - Nucleic Acids
Cell Press | United States

Journal of Medicinal Chemistry
American Chemical Society | United States

See All